As Donald J. Trump gradually fills out his cabinet, the President-elect’s latest pick could bode well for biopharma business ...

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...

Drug companies have paid billions to settle allegations they contributed to the opioid epidemic based on a legal theory that ...

“Partnerships between academia and industry foster innovation, especially in niche areas like therapeutics, biologics, gene ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

NewAmsterdam Pharma's obicetrapib demonstrates strong phase 3 results. Discover why NAMS stock could rise as further studies ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...

South Dakota Gov. Kristi Noem is among the latest of Trump’s nominees to perambulate Capitol Hill. And as of now, her nomination to lead the Department of Homeland Security appears on track for ...

Shares of health insurers such as UnitedHealth and CVS Health fell on Wednesday after a Wall Street Journal report said a ...

Kyverna Therapeutics was sued by an investor that lost money from stock that has fallen almost 80% since its February IPO.

Pharmacy benefit managers have previously come under scrutiny for their influence over prescription drug prices.

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...